This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) | MicrobiomeTrials
← Back to trials NCT06978296
HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-06-01Est. Completion: 2028-05-01
Enrollment target: 18 participantsLocations ICO, Saint-Herblain, France Other microbiome trials you might be interested in Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8 Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients …
Birmingham, United States Est. completion Dec 31, 2026
Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Metastatic Melanoma
Recurrent Melanoma
Unresectable Melanoma
This phase III trial studies how well initial treatment with ipilimumab and nivolumab followed by dabrafenib and trameti…
Birmingham, United States Est. completion Sep 30, 2023
Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Paranasal Sinus Neoplasms Nasopharyngeal Carcinoma Oropharyngeal Squamous Cell Carcinoma Hypopharyngeal Cancer Carcinoma of Larynx Oral Squamous Cell Carcinoma Salivary Gland Cancer Adenoid Cystic Carcinoma Prostate Cancer Metastatic Castration Resistant Prostate Cancer
Background:
Head and neck cancers (HNCs) account for about 5% of all cancers worldwide. They grow in the mouth, throat,…
Bethesda, United States Est. completion Oct 1, 2036